Chen Ruoyu Insider Trades

Insider Trading History

Track insider trading activity for Chen Ruoyu. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Gyre Therapeutics
Gyre Therapeutics GYRE
Chief Financial Officer
Holding Value $310k 50,000 shares
Last Trade
Jan 07, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$366k 50,000 shares
$7.31
$6.19
Gyre Therapeutics
Gyre Therapeutics GYRE
Chief Financial Officer
Holding Value $310k 50,000 shares
Last Trade
Aug 14, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$499k 50,000 shares
$9.98
$6.19
Catalyst Biosciences
Catalyst Biosciences CBIO
Chief Financial Officer
Holding Value $10.7M 578,540 shares
Last Trade
Nov 20, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$296k 578,540 shares
$0.51
$18.45
Gyre Therapeutics
Gyre Therapeutics GYRE
Chief Financial Officer
Holding Value $3.58M 578,540 shares
Last Trade
Nov 20, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$8.49M 578,540 shares
$14.68
$6.19
Gyre Therapeutics
Gyre Therapeutics GYRE
Interim CFO
Holding Value $213k 34,380 shares
Last Trade
Oct 31, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$238k 34,380 shares
$6.93
$6.19
Catalyst Biosciences
Catalyst Biosciences CBIO
Interim CFO
Holding Value $634k 34,380 shares
Last Trade
Oct 31, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$17.6k 34,380 shares
$0.51
$18.45

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up